Comment on the NICE Technology Appraisal Guidance on the use of docetaxel, paclitaxel, gemcitabine and vinorelbine for treatment of non-small lung cancer
NHS Quality Improvement Scotland
Record ID 32002000055
English
Details
Project Status:
Completed
URL for project:
http://www.nhshealthquality.org/
Year Published:
2001
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Scotland, United Kingdom
MeSH Terms
- Carcinoma, Non-Small-Cell Lung
- Docetaxel
- Paclitaxel
- Vinorelbine
- Drug Therapy
- Practice Guidelines as Topic
- Antineoplastic Combined Chemotherapy Protocols
- Deoxycytidine
- Lung Neoplasms
- Taxoids
- Vinblastine
Contact
Organisation Name:
Health Technology Board for Scotland
Contact Address:
Delta House, 50 West Nile Street Glasgow G1 2NP Scotland United Kingdom Tel: +44 141 225 6988; Fax: +44 141 221 3262
Contact Name:
shtg.hcis@nhs.net
Contact Email:
shtg.hcis@nhs.net
Copyright:
Health Technology Board for Scotland (HTBS) (merged into NHS Quality Improvement Scotland (NHS QIS))
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.